Disease Markers / 2020 / Article / Fig 3

Research Article

Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer

Figure 3

Changing trends in serum SPRR2A levels before and after surgery. Serum SPRR2A expression in gastric cancer patients postoperatively, at 38.00 (35.08, 101.05) pg/ml, was significantly lower than that in gastric cancer patients preoperatively, at 133.46 (88.04, 188.01) pg/ml ().

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.